EGFR and non-small cell lung carcinoma: Mutations in the epidermal growth factor receptor (EGFR) gene, such as exon 19 deletions (19del) and Leu858Arg point mutations in exon 21 (L858R), are among the most common driver oncogenes in NSCLC.